Skip to main content

Court Orders Valsartan Defendants To Submit Primary Findings

Court Orders Valsartan Defendants To Submit Primary Findings

Court Orders Valsartan Defendants To Submit Primary Findings

Introduction

According to a court order dated April 29, valsartan recall defendants should submit their findings outlined in the order by June 17, 2019. The core discovery will be limited only to valsartan medications and not losartan or irbesartan products. Any recall defendants failing to submit the findings should inform the court about their intention by May 27. A telephonic conference will be held on May 8, at 3:00 p.m., to finalize the terms of a Discovery Confidentiality Order, followed by an in-person conference on May 29 to finalize the parties’ Profile Forms and Short Form Complaints, as well as an Order regarding the parties’ group organization and leadership.

The recall began last year after carcinogenic nitrosamines were discovered in active pharmaceuticals ingredients manufactured by Zhejiang Huahai Pharmaceutical Co. which was due to some alteration in its production methods. Research shows nitrosamines are linked to gastrointestinal tract cancers, including colon cancer, stomach cancer, and esophageal cancer. Also, nitrosamines may cause liver cancer, kidney cancer, and pancreatic cancer. There are 50 valsartan lawsuits pending in the federal litigation underway in New Jersey. The proceeding involves over 40 valsartan recall defendants, including Zhejiang Huahai, Teva Pharmaceutical Industries Ltd., Mylan NV, and CVS Health Co.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to $7.4B Opioid Settlement

Categories: Opioids

Purdue Pharma and its owners, the Sackler family, have agreed to a $7.4 billion settlement to resolve thousands of lawsuits accusing the…

Paraquat Trials Scheduled for October 2025 & April 2026

Categories: Paraquat

A U.S. District Judge overseeing thousands of federal

UGA College of Pharmacy Gets $1M+ to Fight Opioid Crisis

Categories: Opioids

Faculty from the University of Georgia’s College of Pharmacy have been awarded a nearly $1.2 million grant from the Georgia Opioid Crisis…

Get 5 Free Medical Record Reviews – No Risk, No Contracts!      
Only 10 firms will be accepted!

Valid until February 28, 2025.